Jul 15 |
Milestone Pharmaceuticals Refreshes Board of Directors
|
Jul 9 |
Achieve Life Sciences to Present at JonesHealthcare Seaside Summit 2024
|
Jul 5 |
With 64% ownership of the shares, Achieve Life Sciences, Inc. (NASDAQ:ACHV) is heavily dominated by institutional owners
|
Jul 1 |
Achieve Life Sciences: 1st Half 2025 NDA Filing On Track With FDA Agreement
|
Jul 1 |
Achieve Life Sciences to join U.S. Russell 3000 and Russell Microcap indexes
|
Jul 1 |
Achieve Life Sciences Announces Addition to the U.S. Russell 3000® and Russell Microcap® Indexes
|
May 29 |
Achieve Life Sciences Announces Initiation of ORCA-OL Clinical Trial Evaluating Long-Term Exposure of Cytisinicline in People who Smoke or Use Nicotine E-Cigarettes
|
May 13 |
ACHV: First Quarter Results
|
May 10 |
Achieve Life Sciences Inc (ACHV) Reports Q1 2024 Financial Results
|
May 10 |
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q1 2024 Earnings Call Transcript
|